Literature DB >> 31078668

Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers.

Marco Meloni1, Valentina Izzo2, Laura Giurato2, Roberto Gandini3, Luigi Uccioli2.   

Abstract

AIM: To evaluate the impact of below-the-ankle (BTA) arterial disease in people with ischemic diabetic foot ulcers (DFUs).
METHODS: Patients with ischemic DFUs treated by a pre-set limb salvage protocol including peripheral revascularization were included. They were divided in two groups according to the involvement of BTA arteries (BTA+) or not (BTA-). Not healing, minor amputation, major amputation and mortality have been evaluated as primary outcome. Revascularization failure has been evaluated as secondary outcome.
RESULTS: The study group was composed of 272 patients, 120 (44.1%) belonging to BTA+ group and 152 (55.9%) to BTA-. After 1 year of follow-up the outcomes for BTA+ and BTA- were respectively: not healing (40.8 vs 17.8%, p < 0.0001), minor amputation (80.8 vs 20.4%, p < 0.0001), major amputation (18.3 vs 6.6%, p = 0.002), mortality (16.7% vs 10.5%, p = 0.001). The rate of revascularization failure was respectively 38.3 vs 11.2%, p < 0.0001. At the multivariate analysis BTA arterial disease resulted an independent predictor of not healing [OR 3.5 (CI 95% 2.3-6.1) p = 0.0001], minor amputation [OR 3.1 (1.5-5.9) p < 0.0001] and revascularization failure [OR 3.5 (1.9-6.3) p = 0.0001]. BTA+ patients with successful BTA revascularization showed lower rate of not healing (37.8 vs 89.1%) p < 0.0001, minor amputation (74.3 vs 91.3%) p = 0.002 and major amputation (8.1 vs 34.8%) p = 0.0003 in comparison to patients with unsuccessful BTA revascularization.
CONCLUSION: BTA arterial disease severely impairs the outcomes of diabetics with ischemic foot ulcers. BTA revascularization reduces the rate of not healing, minor and major amputation.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amputation; Diabetes; Diabetic foot ulcers; Peripheral arterial disease; Revascularization

Mesh:

Year:  2019        PMID: 31078668     DOI: 10.1016/j.diabres.2019.04.031

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

1.  Below-the-ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers.

Authors:  Marco Meloni; Alfonso Bellia; Laura Giurato; Davide Lauro; Luigi Uccioli
Journal:  Acta Diabetol       Date:  2022-07-21       Impact factor: 4.087

Review 2.  Therapeutic Alternatives in Diabetic Foot Patients without an Option for Revascularization: A Narrative Review.

Authors:  Gerhard Ruemenapf; Stephan Morbach; Martin Sigl
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

3.  Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers.

Authors:  Gaia Spinetti; Carlo Maria Ferdinando Caravaggi; Andrea Panunzi; Fabiana Madotto; Elena Sangalli; Federica Riccio; Adriana Barbara Sganzaroli; Paolo Galenda; Amelia Bertulessi; Maria Francesca Barmina; Ornella Ludovico; Orazio Fortunato; Francesco Setacci; Flavio Airoldi; Davide Tavano; Laura Giurato; Marco Meloni; Luigi Uccioli; Antonino Bruno
Journal:  Cardiovasc Diabetol       Date:  2022-09-28       Impact factor: 8.949

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.